AMGN vs TECH · P/E 24, rev $36.75B vs P/E 65, rev $1.22B
Amgen Inc (AMGN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AMGN and TECH stock pages for the full models.
Not investment advice.